Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HHLA3 |
| Upstream (Parents) |
|---|
| (<<) SIGIRR → HHLA3 |
| (<<) NRIP1 → HHLA3 |
| (<<) FDXR → HHLA3 |
| (<<) ZMYM1 → HHLA3 |
| (<<) RFNG → HHLA3 |
| (<<) MIA3 → HHLA3 |
| Downstream (Children) |
|---|
| HHLA3 → RS1 (>>) |
| HHLA3 → NRG2 (>>) |
| HHLA3 → ATRIP///TREX1 (>>) |
| HHLA3 → ARL17B///ARL17A (>>) |
| HHLA3 → PHF7 (>>) |
| HHLA3 → ZHX3 (>>) |
| HHLA3 → POLR2L (>>) |
| HHLA3 → UNC119 (>>) |
| HHLA3 → RNLS (>>) |
| HHLA3 → ETV2 (>>) |
| HHLA3 → C17orf81 (>>) |
| HHLA3 → ATP5D (>>) |
| HHLA3 → PMS2L2 (>>) |
| HHLA3 → PPP2R2D (>>) |
| HHLA3 → LIN7B (>>) |
| HHLA3 → METRN (>>) |
| HHLA3 → LOC100129250 (>>) |
| HHLA3 → VAMP2 (>>) |
| HHLA3 → FDXR (>>) |
| HHLA3 → ZMYM1 (>>) |
| HHLA3 → TP53TG1 (>>) |
| HHLA3 → C2orf44 (>>) |
| HHLA3 → HSPB11 (>>) |
| HHLA3 → TNF (>>) |
| HHLA3 → PVR (>>) |
